Earnings Release Notice
Kwangdong Pharmaceutical announced it plans to disclose its financial results for the period from January 1, 2026 to September 30, 2026 on November 11, 2026.
KWANGDONG PHARMACEUTICAL CO.,LTD Disclosures
009290 · KOSPI · Based on DART filings
Disclosures
3 total · 20 per page
· Report on Large Shareholdings
Largest shareholder extends share pledge agreements; stake unchanged at 19.42%
Choi Sung Won and 15 related parties kept their stake in KWANGDONG PHARMACEUTICAL CO.,LTD at 19.42% and extended share pledge agreements.
· Report on Large Shareholdings
Largest shareholder group's stake rises to 19.42% after affiliate's on-market purchases
The stake of the largest shareholder and 15 related parties in KWANGDONG PHARMACEUTICAL CO.,LTD rose from 19.11% to 19.42% after an affiliate's on-market purchases at KRW 6,285–6,448 per share.
Catch the next disclosure fast
Get app alerts for new disclosures from KWANGDONG PHARMACEUTICAL CO.,LTD.